株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

脊髄電気刺激装置:パイプライン分析

Spinal Cord Stimulators - Medical Devices Pipeline Assessment, 2017

発行 GlobalData 商品コード 345363
出版日 ページ情報 英文 105 Pages
即納可能
価格
本日の銀行送金レート: 1USD=110.47円で換算しております。
Back to Top
脊髄電気刺激装置:パイプライン分析 Spinal Cord Stimulators - Medical Devices Pipeline Assessment, 2017
出版日: 2017年07月01日 ページ情報: 英文 105 Pages
概要

当レポートでは、世界各国の企業・医療機関などで開発が進められている脊髄電気刺激装置のパイプライン製品情報について分析しており、治験と製品開発の進行状況、段階別・セグメント別・国 (地域) 別の動向、企業と製品の詳細情報、最近の製品開発および業界の動向などの情報を盛り込んでいます。

第1章 目次

第2章 イントロダクション

  • 脊髄電気刺激装置の概要

第3章 開発中の製品

  • 脊髄電気刺激装置 - 開発段階別のパイプライン製品
  • 脊髄電気刺激装置 - 国 (地域) 別のパイプライン製品
  • 脊髄電気刺激装置 - 規制別のパイプライン製品
  • 脊髄電気刺激装置 - 認証時期別 (推定) のパイプライン製品
  • 脊髄電気刺激装置 - 現在進行中の治験

第4章 脊髄電気刺激装置 - 開発中のパイプライン製品:企業別

  • 脊髄電気刺激装置企業 - 開発段階別のパイプライン製品
  • 脊髄電気刺激装置 - 開発段階別のパイプライン製品

第5章 脊髄電気刺激装置企業と製品の概要

  • Boston Scientific Corporation
  • Direct Spinal Therapeutics, Inc.
  • Duke University
  • Imperial College London
  • Meagan Medical Inc.
  • Medtrode Inc.
  • Medtronic plc
  • MicroTransponder Inc.
  • NeuroRecovery Technologies Inc.
  • Nuvectra Corporation
  • Saluda Medical Pty Ltd
  • St. Jude Medical, Inc.
  • Stimwave Technologies, Inc.

第6章 脊髄電気刺激装置 - 最近の動向

第7章 付録

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次

GlobalData's Medical Devices sector report, "Spinal Cord Stimulators - Medical Devices Pipeline Assessment, 2017" provides an overview of Spinal Cord Stimulators currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Spinal Cord Stimulators pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Spinal Cord Stimulators under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Spinal Cord Stimulators and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Spinal Cord Stimulators under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents

1 Table of Contents 2

  • 1.1 List of Tables 5
  • 1.2 List of Figures 6

2 Introduction 7

  • 2.1 Spinal Cord Stimulators Overview 7

3 Products under Development 8

  • 3.1 Spinal Cord Stimulators - Pipeline Products by Stage of Development 8
  • 3.2 Spinal Cord Stimulators - Pipeline Products by Territory 9
  • 3.3 Spinal Cord Stimulators - Pipeline Products by Regulatory Path 10
  • 3.4 Spinal Cord Stimulators - Pipeline Products by Estimated Approval Date 11
  • 3.5 Spinal Cord Stimulators - Ongoing Clinical Trials 12

4 Spinal Cord Stimulators - Pipeline Products under Development by Companies 13

  • 4.1 Spinal Cord Stimulators Companies - Pipeline Products by Stage of Development 13
  • 4.2 Spinal Cord Stimulators - Pipeline Products by Stage of Development 14

5 Spinal Cord Stimulators Companies and Product Overview 15

  • 5.1 Cerevast Therapeutics Inc Company Overview 15
    • 5.1.1 Cerevast Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 15
  • 5.2 Direct Spinal Therapeutics, Inc. Company Overview 16
    • 5.2.1 Direct Spinal Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 16
  • 5.3 Duke University Company Overview 17
    • 5.3.1 Duke University Pipeline Products & Ongoing Clinical Trials Overview 17
  • 5.4 G-Therapeutics SA Company Overview 18
    • 5.4.1 G-Therapeutics SA Pipeline Products & Ongoing Clinical Trials Overview 18
  • 5.5 Imperial College London Company Overview 21
    • 5.5.1 Imperial College London Pipeline Products & Ongoing Clinical Trials Overview 21
  • 5.6 Mayo Clinic Company Overview 22
    • 5.6.1 Mayo Clinic Pipeline Products & Ongoing Clinical Trials Overview 22
  • 5.7 Meagan Medical Inc. Company Overview 23
    • 5.7.1 Meagan Medical Inc. Pipeline Products & Ongoing Clinical Trials Overview 23
  • 5.8 Medtrode Inc Company Overview 24
    • 5.8.1 Medtrode Inc Pipeline Products & Ongoing Clinical Trials Overview 24
  • 5.9 Medtronic plc Company Overview 25
    • 5.9.1 Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 25
  • 5.10 MicroTransponder Inc. Company Overview 31
    • 5.10.1 MicroTransponder Inc. Pipeline Products & Ongoing Clinical Trials Overview 31
  • 5.11 NeuroRecovery Technologies Inc. Company Overview 32
    • 5.11.1 NeuroRecovery Technologies Inc. Pipeline Products & Ongoing Clinical Trials Overview 32
  • 5.12 PathMaker Neurosystems Inc Company Overview 34
    • 5.12.1 PathMaker Neurosystems Inc Pipeline Products & Ongoing Clinical Trials Overview 34
  • 5.13 Saluda Medical Pty., Ltd. Company Overview 37
    • 5.13.1 Saluda Medical Pty., Ltd. Pipeline Products & Ongoing Clinical Trials Overview 37
  • 5.14 St. Jude Medical LLC Company Overview 40
    • 5.14.1 St. Jude Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 40
  • 5.15 University of California Los Angeles Company Overview 46
    • 5.15.1 University of California Los Angeles Pipeline Products & Ongoing Clinical Trials Overview 46
  • 5.16 WISE S.r.l. Company Overview 47
    • 5.16.1 WISE S.r.l. Pipeline Products & Ongoing Clinical Trials Overview 47

6 Spinal Cord Stimulators- Recent Developments 48

  • 6.1 May 25, 2017: Medtronic Reports Fourth Quarter and Fiscal Year 2017 Financial Results 48
  • 6.2 May 24, 2017: Stimwave Appoints Pat Tompkins as Executive Vice President of Sales 51
  • 6.3 May 09, 2017: Nuvectra Reports First Quarter 2017 Financial Results 51
  • 6.4 May 08, 2017: Nevro Reports First Quarter 2017 Financial Results 52
  • 6.5 Apr 27, 2017: Boston Scientific Announces Results For First Quarter 2017 52
  • 6.6 Apr 21, 2017: Stimwave Awarded U.S. Government DAPA Contract 54
  • 6.7 Apr 07, 2017: Stimwave Announces Regulatory Approval from Australian Therapeutic Goods Administration (TGA) for its Freedom Spinal Cord Stimulation System 54
  • 6.8 Apr 03, 2017: Man moves paralyzed legs using device that stimulates spinal cord 55
  • 6.9 Mar 07, 2017: Nuvectra Reports Fourth Quarter and Full Year 2016 Financial Results 56
  • 6.10 Feb 23, 2017: Nevro Reports Fourth Quarter and Full Year 2016 Financial Results and Provides 2017 Outlook 57
  • 6.11 Feb 21, 2017: Medtronic Reports Third Quarter Financial Results 58
  • 6.12 Feb 15, 2017: Bpifrance awards PathMaker Neurosystems a PIA Grant to Support Product Development 61
  • 6.13 Feb 08, 2017: Alexander P. Hersel, M.D. and Bradley Spiegel, M.D., of Pain Management & Injury Relief Medical Center, achieve transformational results for back and leg pain with an innovative treatment 61
  • 6.14 Feb 06, 2017: Medtronic Awarded U.S. Department of Veterans Affairs National Contracts for Home Telehealth Technologies, with Three Other Vendors 62
  • 6.15 Feb 02, 2017: Boston Scientific Announces Results For Fourth Quarter And Full Year Ended December 31, 2016 63
  • 6.16 Jan 23, 2017: PathMaker Neurosystems and France's Brain and Spine Institute Announce Establishment of Broad Relationship to Conduct European Clinical Trials for MyoRegulator 64
  • 6.17 Jan 23, 2017: Analysis Of Data From Sunburst Study Confirms The Benefits Of Abbott's BurstDR Stimulation 65
  • 6.18 Jan 20, 2017: New Study Demonstrates Spinal Cord Stimulation Can Reduce or Stabilize Opioid Use Among Chronic Pain Patients 66
  • 6.19 Jan 18, 2017: Abbott Announces European Launch Of The Proclaim DRG Neurostimulation System For The Management Of Chronic Neuropathic Pain 67
  • 6.20 Jan 17, 2017: New Data Confirms Abbott's Dorsal Root Ganglion Stimulation Offers Greater Treatment Success Over Traditional Spinal Cord Stimulation 68
  • 6.21 Dec 13, 2016: Experimental Implant Shows Promise for Restoring Voluntary Movement after Spinal Cord Injury 69
  • 6.22 Dec 13, 2016: Experimental implant shows promise for restoring voluntary movement after spinal cord injury 71
  • 6.23 Dec 12, 2016: Nuvectra Corporation Signs Direct Supply Agreement 72
  • 6.24 Dec 09, 2016: Nevro Announces Filing of Lawsuit by Boston Scientific 73
  • 6.25 Dec 08, 2016: St. Jude Medical Receives CE Mark Approval for Full Body MR Conditional Labeling for the Proclaim Elite Spinal Cord Stimulation System 73
  • 6.26 Nov 28, 2016: Nevro Files Lawsuit for Patent Infringement Against Boston Scientific in the U.S. 74
  • 6.27 Nov 22, 2016: Medtronic Reports Second Quarter Financial Results 74
  • 6.28 Nov 16, 2016: Medtronic Releases FY16 Integrated Performance Report 77
  • 6.29 Nov 15, 2016: CEVA to work with Medtronic for distribution facility construction 78
  • 6.30 Nov 14, 2016: St. Jude Medical Announces Full-Body MRI Compatibility And Second Major Upgrade For Proclaim Elite Spinal Cord Stimulation System 78
  • 6.31 Nov 09, 2016: Nuvectra Reports Third Quarter 2016 Financial Results 79
  • 6.32 Nov 07, 2016: Nevro Reports Third Quarter 2016 Financial Results 80
  • 6.33 Oct 26, 2016: Boston Scientific Announces Results For Third Quarter 2016 81
  • 6.34 Oct 25, 2016: Southeast Pain Care is One of the First in North Carolina to Use New Neurostimulation Device for Chronic Pain 83
  • 6.35 Oct 19, 2016: St. Jude Medical Reports Third Quarter 2016 Results 83
  • 6.36 Oct 10, 2016: Professor Ian Meredith To Join Boston Scientific As Executive Vice President And Global Chief Medical Officer 85
  • 6.37 Oct 04, 2016: St. Jude Medical Announces FDA Approval of BurstDR Stimulation, a New Superior Spinal Cord Stimulation Option for Patients Suffering from Chronic Pain 86
  • 6.38 Sep 15, 2016: Medtronic Names Mark Ploof Senior Vice President of Global Operations and Business Services 87
  • 6.39 Sep 13, 2016: PathMaker Neurosystems Announces the Addition of Institute Professor Emilio Bizzi of MIT to its Scientific Advisory Board 88
  • 6.40 Sep 06, 2016: Publication of Two-Year SENZA-RCT Results in Neurosurgery Demonstrates Sustained Superiority of HF10 Therapy over Traditional Spinal Cord Stimulation for Chronic Pain 88
  • 6.41 Aug 29, 2016: Stimwave's Drug-Free Wireless Pain Relief Neurostimulator Changing the Lives of People Suffering From Chronic Pain 89
  • 6.42 Aug 25, 2016: Medtronic Reports First Quarter Financial Results 91
  • 6.43 Aug 23, 2016: Novel Technology for Veterans with Spinal Cord Injury or ALS to be presented at this year's Paralyzed Veterans of America Summit in Orlando: NeuRx Diaphragm Pacing System Shows Benefit In SCI and ALS Patients 93
  • 6.44 Aug 10, 2016: Nuvectra Reports Second Quarter 2016 Financial Results 94
  • 6.45 Aug 09, 2016: Synapse Biomedical Awarded GSA Schedule for NeuRx Diaphragm Pacing System product line; device will benefit veterans with spinal cord injury (SCI) and ALS 95
  • 6.46 Aug 08, 2016: Nuvectra Announces Formation Of Medical Advisory Board 95
  • 6.47 Aug 08, 2016: Nevro Reports Second Quarter 2016 Financial Results 96
  • 6.48 Jul 28, 2016: Boston Scientific Announces Results For Second Quarter 2016 97
  • 6.49 Jul 20, 2016: St. Jude Medical Reports Second Quarter 2016 Results 99
  • 6.50 Jul 13, 2016: Boston Scientific Elects Yoshiaki Fujimori to Board of Directors 101
  • 6.51 Jun 30, 2016: NuVasive Agrees to Settle Patent Litigation With Medtronic 101

7 Appendix 102

  • 7.1 Methodology 102
  • 7.2 About GlobalData 105
  • 7.3 Contact Us 105
  • 7.4 Disclaimer 105

List of Tables

1.1 List of Tables

  • Table 1: Spinal Cord Stimulators - Pipeline Products by Stage of Development 8
  • Table 2: Spinal Cord Stimulators - Pipeline Products by Territory 9
  • Table 3: Spinal Cord Stimulators - Pipeline Products by Regulatory Path 10
  • Table 4: Spinal Cord Stimulators - Pipeline Products by Estimated Approval Date 11
  • Table 5: Spinal Cord Stimulators - Ongoing Clinical Trials 12
  • Table 6: Spinal Cord Stimulators Companies - Pipeline Products by Stage of Development 13
  • Table 7: Spinal Cord Stimulators - Pipeline Products by Stage of Development 14
  • Table 8: Cerevast Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 15
  • Table 9: Transdermal Electrical Neurostimulation Device - Product Status 15
  • Table 10: Transdermal Electrical Neurostimulation Device - Product Description 15
  • Table 11: Direct Spinal Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 16
  • Table 12: Iowa-Patch System - Product Status 16
  • Table 13: Iowa-Patch System - Product Description 16
  • Table 14: Duke University Pipeline Products & Ongoing Clinical Trials Overview 17
  • Table 15: Spinal Cord Stimulator - Product Status 17
  • Table 16: Spinal Cord Stimulator - Product Description 17
  • Table 17: G-Therapeutics SA Pipeline Products & Ongoing Clinical Trials Overview 18
  • Table 18: Implantable Neuro-Stimulation System - Product Status 18
  • Table 19: Implantable Neuro-Stimulation System - Product Description 18
  • Table 20: G-Therapeutics SA - Ongoing Clinical Trials Overview 19
  • Table 21: Implantable Neuro-Stimulation System - Feasibility Study: fMRI Evaluation of Auricular PENFS for Fibromyalgia 20
  • Table 22: Imperial College London Pipeline Products & Ongoing Clinical Trials Overview 21
  • Table 23: Wireless Intraspinal Microstimulation System - Product Status 21
  • Table 24: Wireless Intraspinal Microstimulation System - Product Description 21
  • Table 25: Mayo Clinic Pipeline Products & Ongoing Clinical Trials Overview 22
  • Table 26: Spinal Cord Electrical Stimulator - Product Status 22
  • Table 27: Spinal Cord Electrical Stimulator - Product Description 22
  • Table 28: Meagan Medical Inc. Pipeline Products & Ongoing Clinical Trials Overview 23
  • Table 29: DISCSS IFC System - Product Status 23
  • Table 30: DISCSS IFC System - Product Description 23
  • Table 31: Medtrode Inc Pipeline Products & Ongoing Clinical Trials Overview 24
  • Table 32: Implantable Pulse Generator - Product Status 24
  • Table 33: Implantable Pulse Generator - Product Description 24
  • Table 34: Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 25
  • Table 35: Intellis RC - Product Status 25
  • Table 36: Intellis RC - Product Description 26
  • Table 37: MRI Surgical Lead - Product Status 26
  • Table 38: MRI Surgical Lead - Product Description 26
  • Table 39: PNS Device - Chronic Back Pain - Product Status 27
  • Table 40: PNS Device - Chronic Back Pain - Product Description 27
  • Table 41: PrimeADVANCED - Heart Failure - Product Status 27
  • Table 42: PrimeADVANCED - Heart Failure - Product Description 28
  • Table 43: Medtronic plc - Ongoing Clinical Trials Overview 29
  • Table 44: PrimeADVANCED - Heart Failure - Evaluation of Rate Adaptive Pacing on Chronotropic Response in Preserved Ejection Fraction HF 30
  • Table 45: MicroTransponder Inc. Pipeline Products & Ongoing Clinical Trials Overview 31
  • Table 46: SAINT System - Chronic Pain - Product Status 31
  • Table 47: SAINT System - Chronic Pain - Product Description 31
  • Table 48: NeuroRecovery Technologies Inc. Pipeline Products & Ongoing Clinical Trials Overview 32
  • Table 49: External Spinal Cord Neuromodulation System - Product Status 32
  • Table 50: External Spinal Cord Neuromodulation System - Product Description 32
  • Table 51: Implantable Spinal Cord Stimulation Device - Product Status 33
  • Table 52: Implantable Spinal Cord Stimulation Device - Product Description 33
  • Table 53: PathMaker Neurosystems Inc Pipeline Products & Ongoing Clinical Trials Overview 34
  • Table 54: MyoRegulator PM-2200 - Product Status 34
  • Table 55: MyoRegulator PM-2200 - Product Description 34
  • Table 56: PathMaker Neurosystems Inc - Ongoing Clinical Trials Overview 35
  • Table 57: MyoRegulator PM-2200 - First Clinical Trial of MyoRegulator to Treat Muscle Contraction 36
  • Table 58: MyoRegulator PM-2200 - First European Clinical Trial of MyoRegulator to Treat Muscle Contraction 36
  • Table 59: MyoRegulator PM-2200 - The Effect of Treatment with the Pathmaker Myoregulator Neuromodulation System Incorporating Trans-spinal Direct Current Stimulation (tsDCS) in Patients with Severe Hand Spasticity after Stroke 36
  • Table 60: Saluda Medical Pty., Ltd. Pipeline Products & Ongoing Clinical Trials Overview 37
  • Table 61: Evoke Spinal Cord Stimulator System - Product Status 37
  • Table 62: Evoke Spinal Cord Stimulator System - Product Description 37
  • Table 63: Saluda Medical Pty., Ltd. - Ongoing Clinical Trials Overview 38
  • Table 64: Evoke Spinal Cord Stimulator System - A Prospective, Multicenter, Randomized Double-blind Study Examining the Safety and Efficacy of Using the Evoke Spinal Cord Stimulator (SCS) System with Feedback to Treat Patients with Chronic Pain of the Trunk and/or Limbs 39
  • Table 65: St. Jude Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 40
  • Table 66: Next Generation Implantable SCS System - Primary Cell - Product Status 40
  • Table 67: Next Generation Implantable SCS System - Primary Cell - Product Description 40
  • Table 68: Next Generation Implantable SCS System - Rechargeable - Product Status 41
  • Table 69: Next Generation Implantable SCS System - Rechargeable - Product Description 41
  • Table 70: Proclaim Rechargeable Model - Product Status 41
  • Table 71: Proclaim Rechargeable Model - Product Description 41
  • Table 72: Proclaim Upgrade HC - Product Status 42
  • Table 73: Proclaim Upgrade HC - Product Description 42
  • Table 74: Proclaim Upgrade LC - Product Status 42
  • Table 75: Proclaim Upgrade LC - Product Description 43
  • Table 76: Prodigy SCS System - Product Status 43
  • Table 77: Prodigy SCS System - Product Description 43
  • Table 78: St. Jude Medical LLC - Ongoing Clinical Trials Overview 44
  • Table 79: Prodigy SCS System - Multi-center Prospective Study Determining the Sustainability of Pain Relief and Psychosocial and Functional Responses when Utilizing a Multiple Waveform Enabled Neurostimulator 45
  • Table 80: University of California Los Angeles Pipeline Products & Ongoing Clinical Trials Overview 46
  • Table 81: 32-Electrode Neurostimulator - Product Status 46
  • Table 82: 32-Electrode Neurostimulator - Product Description 46
  • Table 83: WISE S.r.l. Pipeline Products & Ongoing Clinical Trials Overview 47
  • Table 84: Foldable SCS Paddle Leads - Product Status 47
  • Table 85: Foldable SCS Paddle Leads - Product Description 47
  • Table 86: Glossary 104

List of Figures

1.2 List of Figures

  • Figure 1: Spinal Cord Stimulators - Pipeline Products by Stage of Development 8
  • Figure 2: Spinal Cord Stimulators - Pipeline Products by Territory 9
  • Figure 3: Spinal Cord Stimulators - Pipeline Products by Regulatory Path 10
  • Figure 4: Spinal Cord Stimulators - Pipeline Products by Estimated Approval Date 11
  • Figure 5: Spinal Cord Stimulators - Ongoing Clinical Trials 12
Back to Top